DC Sane, RM Califf, EJ Topol, DC Stump, … - Annals of internal …, 1989 - Am Coll Physicians Hemorrhage is the major adverse effect of thrombolytic therapy, but its incidence can be reduced
by careful selection of patients and avoidance of unnecessary invasive procedures. More than
70% of bleeding episodes occur at vascular puncture sites. Hypofibrinogenemia and ... Cited by 82 - Related articles - All 3 versions
RM Califf, EJ Topol, BS George, JM Boswick, C … - The American Journal of …, 1988 - Elsevier : Quantitation of blood loss during the patients' hospital stay included a median drop in hematocrit
of 11.4 points, a median nadir hematocrit of 31.2, a 14 percent rate of significant clinically evident
bleeding, and a 31 percent rate of transfusion of two or more units of blood. All of these ... Cited by 85 - Related articles - All 4 versions
RM Califf, DF Fortin, AN Tenaglia, DC … - The American journal of …, 1992 - ncbi.nlm.nih.gov Understanding the clinical risks of intravenous thrombolytic therapy is critical to appropriate patient
selection. The major risks can be classified into 5 major categories: intracranial hemorrhage,
systemic hemorrhage, immunologic complications, hypotension, and myocardial rupture. ... Cited by 65 - Related articles - All 2 versions
JP Bassand, J Machecourt, J Cassagnes, … - Journal of the …, 1989 - Am Coll Cardio Found Two hundred thirty-one patients with a first acute myocardial infarction were randomly allocated
within 5 h after the onset of symptoms either to treatment with anisoylated plasminogen streptokinase
activator complex (APSAC), 30 U over 5 min, or to conventional heparin therapy, 5,000 IU ... Cited by 54 - Related articles - All 3 versions
- ►chestjournal.org [PDF] PE Nathan, AV Torres, AJ Smith, AJ Gagliardi, KB … - Chest, 1992 - Am Coll Chest Phys Page 1. DOI 10.1378/chest.101.4.1150 1992;101;1150-1152 Chest PE Nathan, AV
Torres, AJ Smith, AJ Gagliardi and KB Rapeport coronary thrombolysis. Spontaneous
pulmonary hemorrhage following http://www.chestjournal ... Cited by 11 - Related articles - All 6 versions
WS Schroeder, PJ Gandhi - Current Cardiology Reports, 2003 - Springer Introduction Plaque rupture, thrombus development, and occlusion of the coronary vasculature
is the primary pathogenesis of acute coronary syndromes (ACS). Pharmacologic manage- ment
is directed toward restoration of coronary blood flow to the ischemic myocardium, limiting ... Cited by 14 - Related articles - BL Direct - All 2 versions
- ►ahajournals.org [PDF] LW Gimple, HK Gold, RC Leinbach, BS Coller, W … - Circulation, 1989 - Am Heart Assoc Lawrence W. Gimple, MD, Herman K. Gold, MD, Robert C. Leinbach, MD, ... Barry S. Coller,
MD, Wendy Werner, RN, Tsunehiro Yasuda, ... Andrew A. Ziskind, MD, Dianne Finkelstein,
PhD, and Desire Collen, ... The purpose of this study was to correlate bleeding ... Cited by 48 - Related articles - All 3 versions
CB Granger, RM Califf, EJ Topol - Drugs, 1992 - ncbi.nlm.nih.gov In the past 10 years, thrombolytics have become standard therapy for acute myocardial
infarction. Although the ability of streptokinase to lyse clot was first recognised in the 1930s, thrombolytic
therapy was not used to treat acute myocardial infarction until the early 1980s, when the ... Cited by 135 - Related articles - All 2 versions
[CITATION] for the TIMI investigators. Thrombolysis In Myocardial Infarction (TIMI) trial-Phase I. …
JJ Popma, EJ Topol - Annals of internal medicine, 1991 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Objective: To discuss adjunctive
pharmacologic agents for acute myocardial infarction, to critique their initial effects in ... Cited by 36 - Related articles - All 3 versions
